Ibrutinib
Ibrutinib is an irreversible inhibitor of BTK (IC50: 0.5 nM) that selectively blocks B cell activation.
| Catalog Number | T1835 |
| Alternative Name(s) | PCI-32765 |
| Research Area | Angiogenesis|||Tyrosine Kinase/Adaptors|||PROTAC |
| Molecular Formula | C25H24N6O2 |
| CAS# | 936563-96-1 |
| Purity | 99.79% |
| SMILES | Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/Ibrutinib |
| Additional Information | https://www.targetmol.com/datasheet/T1835 |